A Registry for People With T-cell Lymphoma

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorMemorial Sloan Kettering Cancer Center

About this trial

The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more about how to improve outcomes for people with T-cell lymphoma.

Eligibility criteria

Qualifiers

Written informed consent

Adequate fresh or archival tumor biopsy or intent to obtain fresh tumor biopsy.

T-cell prolymphocytic leukemia

T-cell large granular lymphocytic leukemia

Disqualifiers

Patients with of mycosis fungoides, primary cutaneous anaplastic large cell lymphoma, and/or primary cutaneous acral CD8+ T-cell lymphoma not receiving systemic therapy.

Inability to collect prospective data, measure response, or perform adequate follow-up assessments in the clinical judgment of the treating physician. NOTE: Repository participation does not exclude participation in clinical trials, nor does existing clinical trial participation exclude enrollment in the study herein outlined.

Trial design

Treatments tested in this trial

  • Optional Blood Sample and Nail Sample

Treatment groups

1,000 Participants
are divided into 1 treatment group